285 high-priced antihypertensive drugs to be delisted from health insurance

Published: 2010-09-17 06:57:00

Updated: 2010-09-17 06:57:00

The Health Insurance Review Assessment and Service said on September 15 it will exclude a total of 285 antihypertensive agents from health insurance coverage within this year, since they are deemed to less cost-effective items and in the 80-percent pricing level over original drugs.

The drug agency said it has evaluated the economic effectiveness of insurance-covered medicines before Decembe...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.